세계의 시퀀싱 소모품 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2033년)

Global Sequencing Consumables Market size is anticipated to grow from USD 9.16 Billion in 2024 to USD 60.18 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 23.27% during the forecast period of 2026 to 2033.

The Sequencing Consumables market is poised for significant growth as advancements in genomic research and personalized medicine continue to drive demand for sequencing technologies. Sequencing consumables, which include reagents, kits, and other materials used in DNA and RNA sequencing processes, are essential for various applications in research, clinical diagnostics, and biotechnology. As the demand for high-throughput sequencing and genomic analysis continues to rise, the sequencing consumables market is expected to expand significantly.

Technological advancements in sequencing technologies and methodologies are playing a crucial role in shaping the Sequencing Consumables market. Innovations in next-generation sequencing (NGS) and single-cell sequencing are enhancing the efficiency and accuracy of genomic analysis, making sequencing consumables more appealing to researchers and healthcare providers. Additionally, the rise of personalized medicine and targeted therapies is driving demand for consumables that enable precise genomic profiling and diagnostics. As manufacturers continue to invest in research and development, the potential for new consumable products and applications will drive growth in the sequencing consumables market.

Moreover, the increasing focus on health and wellness is influencing the Sequencing Consumables market landscape. As consumers and healthcare professionals seek to understand genetic predispositions and tailor treatments accordingly, the demand for sequencing technologies and consumables is rising. Many research institutions and clinical laboratories are adopting advanced sequencing methods to enhance patient care and improve health outcomes. The integration of sequencing consumables into broader healthcare initiatives will further enhance their appeal. As the market matures, the convergence of technology, health trends, and consumer preferences will be key drivers of growth, positioning sequencing consumables as essential components in modern genomic research and diagnostics.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product

• Kits
• Reagents
• Accessories

By Platform

• 1st Generation Sequencing Consumables
• 2nd Generation Sequencing Consumables
• 3rd Generation Sequencing Consumables

By Application

• Cancer Diagnostics
• Infectious Disease Diagnostics
• Reproductive Health Diagnostics
• Pharmacogenomics
• Agrigenomics
• Others

By End-use

• Pharmaceutical and Biotechnology Companies
• Hospitals and Laboratories
• Academic Research Institutes
• Others
• COMPANIES PROFILED
• Hoffmann-La Roche Ltd
• QIAGEN
• Agilent Technologies
• Millipore Sigma
• Takara Bio Inc
• Beckman Coulter Inc
• Eurofins Genomics
• Oxford Nanopore Technologies Ltd
• Thermo Fisher Scientific Inc
• BGI Genomics
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. SEQUENCING CONSUMABLES INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Platform
  • 3.7.3 Market Attractiveness Analysis By Application
  • 3.7.4 Market Attractiveness Analysis By End-use
  • 3.7.5 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL SEQUENCING CONSUMABLES MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Kits Historic and Forecast Sales By Regions
• 5.4. Reagents Historic and Forecast Sales By Regions
• 5.5. Accessories Historic and Forecast Sales By Regions

6. GLOBAL SEQUENCING CONSUMABLES MARKET ANALYSIS BY PLATFORM

• 6.1. Overview By Platform
• 6.2. Historical and Forecast Data Analysis By Platform
• 6.3. 1st Generation Sequencing Consumables Historic and Forecast Sales By Regions
• 6.4. 2nd Generation Sequencing Consumables Historic and Forecast Sales By Regions
• 6.5. 3rd Generation Sequencing Consumables Historic and Forecast Sales By Regions

7. GLOBAL SEQUENCING CONSUMABLES MARKET ANALYSIS BY APPLICATION

• 7.1. Overview By Application
• 7.2. Historical and Forecast Data Analysis By Application
• 7.3. Cancer Diagnostics Historic and Forecast Sales By Regions
• 7.4. Infectious Disease Diagnostics Historic and Forecast Sales By Regions
• 7.5. Reproductive Health Diagnostics Historic and Forecast Sales By Regions
• 7.6. Pharmacogenomics Historic and Forecast Sales By Regions
• 7.7. Agrigenomics Historic and Forecast Sales By Regions
• 7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL SEQUENCING CONSUMABLES MARKET ANALYSIS BY END-USE

• 8.1. Overview By End-use
• 8.2. Historical and Forecast Data Analysis By End-use
• 8.3. Pharmaceutical and Biotechnology Companies Historic and Forecast Sales By Regions
• 8.4. Hospitals and Laboratories Historic and Forecast Sales By Regions
• 8.5. Academic Research Institutes Historic and Forecast Sales By Regions
• 8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL SEQUENCING CONSUMABLES MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE SEQUENCING CONSUMABLES COMPANIES

• 10.1. Sequencing Consumables Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF SEQUENCING CONSUMABLES INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Hoffmann-La Roche Ltd
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. QIAGEN
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Agilent Technologies
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Millipore Sigma
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Takara Bio Inc
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Beckman Coulter Inc
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Eurofins Genomics
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Oxford Nanopore Technologies Ltd
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. Thermo Fisher Scientific Inc
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. BGI Genomics
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies